Back to 
Baker Bros. Advisors LP
Baker Bros. Advisors LP
AXSM
Showing 0 of 14 quarters
Position history for Baker Bros. Advisors LP's holdings in Axsome Therapeutics, Inc.
No. Baker Bros. Advisors exited its AXSM (Axsome Therapeutics) position in Q2 2022. Its Q1 2022 13F listed 610,970 shares worth $25.3M. Baker Bros. Advisors already held AXSM in its Q1 2019 13F, the earliest on record, and held it in 13 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.